The treatment of Burkitt lymphoma in adults
Jennifer L. Crombie(Dana-Farber Cancer Institute), Ann S. LaCasce(Otsuka (Japan))
Cited by 105
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
|The Lancet Oncology|2010|852
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
|Journal of Clinical Oncology|2017|468
Non-Hodgkin’s Lymphomas
|Journal of the National Comprehensive Cancer Network|2010|329